Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

RTTNews | 630 일 전
Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

(RTTNews) - Pharmaceutical companies Astellas Pharma Inc. (ALPMY.PK) and Poseida Therapeutics, Inc. (PSTX) announced Monday a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy.

Under the terms of the transaction agreements, Astellas will invest a total of $50 million, including $25 million to acquire 8.3 million shares of common stock of Poseida or approximately 8.8% of the outstanding common stock of Poseida, at $3.00 per share in a private placement.

It will also make a one-time $25 million payment for a right of exclusive negotiation and first refusal to license one of Poseida's clinical stage programs: P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy in development for multiple solid tumor indications.

In addition, Poseida has granted Astellas a board observer seat, which includes the ability to attend Poseida's scientific advisory board meetings, and certain notice rights related to any potential change of control of Poseida.

read more
Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Inc. announced Friday the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI (enzalutamide) as monotherapy or in combination with androgen deprivation therapy for the treatment of adult men with high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiotherapy.
RTTNews | 402 일 전
DAX Rises Nearly 1% As Investors Await Corporate Earnings Updates

DAX Rises Nearly 1% As Investors Await Corporate Earnings Updates

The German market is up firmly in positive territory on Monday as investors pick up stocks ahead of a slew of earnings announcements, and some crucial economic data due this week. Optimism about an improvement in U.S.-China trade relations also appears to be supporting the market.
RTTNews | 20 분 전
European Shares Edge Higher In Cautious Trade

European Shares Edge Higher In Cautious Trade

European stocks traded higher on Monday as tariff tensions eased and investors looked ahead to a busy week of earnings, with four of the Magnificent Seven companies— Amazon, Apple, Meta Platforms and Microsoft — due to report their quarterly results.
RTTNews | 1 시간 19 분 전
European Shares Seen Opening Up In Cautious Trade

European Shares Seen Opening Up In Cautious Trade

European stocks are likely to open on a steady note Monday after U.S. stocks posted their longest advance in three months on Friday amid signs of easing trade tensions and bets the Federal Reserve will cut interest rates as early as June, as the American economy softens.
RTTNews | 4 시간 43 분 전
Sensex, Nifty Follow Global Peers Higher

Sensex, Nifty Follow Global Peers Higher

Indian shares were trading higher on Monday, tracking firm cues from global markets. The benchmark S&P/BSE was up 548 points, or 0.7 percent, at 79,760 despite rising tensions between India and Pakistan, triggered by the Pahalgam terror attack.
RTTNews | 5 시간 59 분 전
Australian Market Trims Early Gains In Mid-market

Australian Market Trims Early Gains In Mid-market

The Australian stock market is trimming its early gains in mid-market trading on Monday, adding to the gains in the previous two sessions, following the broadly positive cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is moving well above the 8,000.00 mark, with gains technology, energy and financial stocks partially offset by weakness in mining stocks.
RTTNews | 6 시간 57 분 전